Literature DB >> 22397944

Effectiveness of the LUCAS device for mechanical chest compression after cardiac arrest: systematic review of experimental, observational and animal studies.

Simon Gates1, Jessica L Smith, Giok J Ong, Samantha J Brace, Gavin D Perkins.   

Abstract

CONTEXT: The LUCAS mechanical chest compression device may be better than manual chest compression during resuscitation attempts after cardiac arrest.
OBJECTIVE: To summarise the evidence about the effectiveness of LUCAS. DATA SOURCES: Searches of 4 electronic databases, reference lists of included studies, review articles, clinical guidelines, and the manufacturer's web site. No language restrictions were applied. Date of last search: September 2011. STUDY SELECTION: All studies, of any design, comparing mechanical chest compression using LUCAS with manual chest compression, with human or animal subjects. Studies published only as abstracts were included. Manikin studies, and case reports or case series, were excluded. DATA EXTRACTION: Data were extracted on study methodology and outcomes, including return of spontaneous circulation, survival, injuries caused by resuscitation, and physiological parameters.
RESULTS: 22 papers reporting 16 separate studies were included. There was one randomised trial, nine cohort studies, 2 before/after studies and 4 animal studies. No meta-analyses were performed because of high risk of bias and heterogeneity in the study designs. Animal studies suggested an advantage to LUCAS in terms of physiological parameters, but human studies did not suggest an advantage in ROSC or survival. Existing evidence is low quality because most studies were small and many were poorly reported.
CONCLUSIONS: There is insufficient evidence to make any recommendations for clinical practice. Large scale, high quality randomised trials of LUCAS are needed. Studies that have so far been published only as abstracts should be reported fully.

Entities:  

Mesh:

Year:  2012        PMID: 22397944     DOI: 10.1136/heartjnl-2011-301571

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  6 in total

1.  Mechanical Chest Compressions in Prolonged Cardiac Arrest due to ST Elevation Myocardial Infarction Can Cause Myocardial Contusion.

Authors:  Cyril Stechovsky; Petr Hajek; Simon Cipro; Josef Veselka
Journal:  Int J Angiol       Date:  2015-01-12

Review 2.  Out-of-hospital cardiac arrest -optimal management.

Authors:  Georg M Fröhlich; Richard M Lyon; Comilla Sasson; Tom Crake; Mark Whitbread; Andreas Indermuehle; Adam Timmis; Pascal Meier
Journal:  Curr Cardiol Rev       Date:  2013-11

3.  Automated mechanical cardiopulmonary resuscitation devices versus manual chest compressions in the treatment of cardiac arrest: protocol of a systematic review and meta-analysis comparing machine to human.

Authors:  Manuel Obermaier; Johannes B Zimmermann; Erik Popp; Markus A Weigand; Sebastian Weiterer; Alexander Dinse-Lambracht; Claus-Martin Muth; Benedikt L Nußbaum; Jan-Thorsten Gräsner; Stephan Seewald; Katrin Jensen; Svenja E Seide
Journal:  BMJ Open       Date:  2021-02-15       Impact factor: 2.692

4.  Comparison between manual and mechanical chest compressions during resuscitation in a pediatric animal model of asphyxial cardiac arrest.

Authors:  Jorge López; Sarah N Fernández; Rafael González; María J Solana; Javier Urbano; Blanca Toledo; Jesús López-Herce
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

5.  Corpuls CPR Generates Higher Mean Arterial Pressure Than LUCAS II in a Pig Model of Cardiac Arrest.

Authors:  S Eichhorn; A Mendoza; A Prinzing; A Stroh; L Xinghai; M Polski; M Heller; H Lahm; E Wolf; R Lange; M Krane
Journal:  Biomed Res Int       Date:  2017-12-17       Impact factor: 3.411

6.  Emergency admission risk stratification tools in UK primary care: a cross-sectional survey of availability and use.

Authors:  Mark Kingston; Rhiannon Griffiths; Hayley Hutchings; Alison Porter; Ian Russell; Helen Snooks
Journal:  Br J Gen Pract       Date:  2020-10-01       Impact factor: 5.386

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.